Coagulation Factor XIIIA (F13A1): Novel Perspectives in Treatment and Pharmacogenetics

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|11|1449-1459

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.11, 2016-03, pp. : 1449-1459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Blockade of Insulin-Like Growth Factor Type-1 Receptor with Cixutumumab (IMC-A12): A Novel Approach to Treatment for Multiple Cancers

By  

Current Drug Targets, Vol. 12, Iss. 14, 2011-12 ,pp. : 2016-2033

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics for the Individualization of Psychiatric Treatment

By Arranz M.J.   Collier D.   Kerwin R.W.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 1, 2001-01 ,pp. : 3-10

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of tenofovir treatment

By Rodriguez-Novoa Sonia   Labarga Pablo   Soriano Vincent  

Pharmacogenomics, Vol. 10, Iss. 10, 2009-10 ,pp. : 1675-1685

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics in Treatment of Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 16, Iss. 2, 2010-01 ,pp. : 164-175

Bentham Science Publishers

Access to resources Recommend Favorite

Relationship between the antithrombotic effect of YM-75466, a novel factor Xa inhibitor, and coagulation parameters in rats

By Sato K.   Taniuchi Y.   Kawasaki T.   Hirayama F.   Koshio H.   Matsumoto Y.  

European Journal of Pharmacology, Vol. 347, Iss. 2, 1998-04 ,pp. : 231-236

Elsevier

Access to resources Recommend Favorite